M
577.30
-8.91 (-1.52%)
| 前收盘价格 | 586.21 |
| 收盘价格 | 585.39 |
| 成交量 | 220,890 |
| 平均成交量 (3个月) | 347,382 |
| 市值 | 13,111,302,144 |
| 价格/销量 (P/S) | 17.88 |
| 股市价格/股市净资产 (P/B) | 21.67 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业毛利率 | -123.38% |
| 营业利益率 (TTM) | -57.79% |
| 稀释每股收益 (EPS TTM) | -17.83 |
| 总债务/股东权益 (D/E MRQ) | 16.85% |
| 流动比率 (MRQ) | 5.91 |
| 营业现金流 (OCF TTM) | -395.31 M |
| 杠杆自由现金流 (LFCF TTM) | -274.11 M |
| 资产报酬率 (ROA TTM) | -25.56% |
| 股东权益报酬率 (ROE TTM) | -50.16% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Madrigal Pharmaceuticals, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.0
| 分析师共识 | -1.5 |
| 内部交易活动 | -3.0 |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.00 |
|
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 7.73% |
| 机构持股比例 | 108.28% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Paulson & Co. Inc. | 30 Sep 2025 | 1,907,523 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 650.00 (Oppenheimer, 12.59%) | 购买 |
| 中 | 573.50 (-0.66%) | |
| 低 | 445.00 (B of A Securities, -22.92%) | 保留 |
| 平均值 | 571.13 (-1.07%) | |
| 总计 | 7 购买, 1 保留 | |
| 平均价格@调整类型 | 490.67 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 21 Nov 2025 | 620.00 (7.40%) | 购买 | 547.96 |
| 11 Nov 2025 | 568.00 (-1.61%) | 购买 | 541.50 | |
| Oppenheimer | 20 Nov 2025 | 650.00 (12.59%) | 购买 | 542.12 |
| 10 Oct 2025 | 590.00 (2.20%) | 购买 | 429.60 | |
| Truist Securities | 19 Nov 2025 | 640.00 (10.86%) | 购买 | 555.60 |
| 15 Oct 2025 | 580.00 (0.47%) | 购买 | 433.45 | |
| Canaccord Genuity | 13 Nov 2025 | 587.00 (1.68%) | 购买 | 514.93 |
| 12 Sep 2025 | 526.00 (-8.89%) | 购买 | 432.22 | |
| Citizens | 05 Nov 2025 | 527.00 (-8.71%) | 购买 | 475.87 |
| B of A Securities | 03 Nov 2025 | 445.00 (-22.92%) | 保留 | 412.35 |
| Piper Sandler | 15 Oct 2025 | 540.00 (-6.46%) | 购买 | 433.45 |
| B. Riley Securities | 29 Sep 2025 | 560.00 (-3.00%) | 购买 | 443.10 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合